Literature DB >> 28025427

The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.

Jelena Carkic1, Nadja Nikolic, Sanja Radojevic-Skodric, Jovana Kuzmanovic-Pficer, Gavrilo Brajovic, Marija Antunovic, Jelena Milasin, Branka Popovic.   

Abstract

The aim of this study was to assess TERT-CLPTM1L single-nucleotide polymorphisms (SNPs) (rs402710 C/T in the CLPTM1L gene; rs2736100 A/C and rs2736098 G/A in the TERT gene) as risk factors for development of oral squamous cell carcinoma (OSCC), and to investigate the relationship between the analyzed polymorphisms, relative telomere length (RTL), telomerase expression and clinicopathologic characteristics of OSCC in a Serbian population. Paraffin-embedded tumor samples and buccal swabs from cancer-free controls were genotyped using PCR-RFLP, while tumor RTL values and telomerase expression were estimated by real-time PCR and immunohistochemistry, respectively. CLPTM1L rs402710 and TERT rs2736100 polymorphisms were associated with a significantly increased risk of OSCC, and TERT rs2736098 with a significantly decreased risk. No significant association was found between TERT-CLPTM1L polymorphisms, tumor RTL values, telomerase expression, and clinicopathologic features, although a trend towards longer telomeres was evident in telomerase-positive samples and less advanced tumors. Kaplan-Meier survival analysis showed that patients with longer telomeres in their tumors had significantly better overall survival than patients with shorter telomeres. Our research seems to provide strong evidence for an association between CLPTM1L rs402710C/T and TERT rs2736100A/C SNPs and the risk of OSSC, and suggests that higher tumor RTL values and positive hTERT expression may be applicable as early prognostic markers.(J Oral Sci 58, 449-458, 2016).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28025427     DOI: 10.2334/josnusd.16-0108

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  6 in total

1.  Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?

Authors:  Puneet Gandhi; Richa Khare; Nitin Garg
Journal:  J Neurooncol       Date:  2017-07-29       Impact factor: 4.130

2.  TERT rs2736098 (Ex2-659G>A) polymorphism and cancer susceptibility: evidence from a comprehensive meta-analysis.

Authors:  Tingyuan Pang; Minjie Zhou; Rumin Liu; Jia Luo; Renfei Xia
Journal:  Oncotarget       Date:  2017-10-09

3.  TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.

Authors:  Xinyu Zhang; Yan Chen; Donglin Yan; Jing Han; Longbiao Zhu
Journal:  Biochem Genet       Date:  2021-06-28       Impact factor: 1.890

4.  Association Between TERT rs2736098 Polymorphisms and Cancer Risk-A Meta-Analysis.

Authors:  Mi Zhou; Bo Jiang; Mao Xiong; Xin Zhu
Journal:  Front Physiol       Date:  2018-04-11       Impact factor: 4.566

Review 5.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

6.  CLPTM1L Is a Novel Putative Oncogene Promoting Tumorigenesis in Oral Squamous Cell Carcinoma.

Authors:  Yunwen Hou; Feifei Xue; Yu Fu; Guanying Feng; Ruixia Wang; Hua Yuan
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.